Home Cart Sign in  
Chemical Structure| 93366-88-2 Chemical Structure| 93366-88-2
Chemical Structure| 93366-88-2

*Storage: Keep in dark place,Inert atmosphere,Room temperature.

*Shipping: Normal

7H-Pyrrolo[2,3-d]pyrimidin-2-amine

CAS No.: 93366-88-2

4.5 *For Research Use Only !

Cat. No.: A136969 Purity: 97%

Change View

Size Price

USA Stock *0-1 Day

Global Stock *5-7 Days

In Stock
100mg ł§Í¶ÊÊ In Stock In Stock Login
250mg łÿ˶ÊÊ In Stock In Stock Login
1g łËÊò¶ÊÊ In Stock In Stock Login
5g łďîʶÊÊ In Stock In Stock Login

Please Login or Create an Account to: See VIP prices and availability

  • 100mg

    ł§Í¶ÊÊ

  • 250mg

    łÿ˶ÊÊ

  • 1g

    łËÊò¶ÊÊ

  • 5g

    łďîʶÊÊ

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Product Details of [ 93366-88-2 ]

CAS No. :93366-88-2
Formula : C6H6N4
M.W : 134.14
SMILES Code : NC1=NC2=C(C=CN2)C=N1
MDL No. :MFCD12923656
InChI Key :YVVMIGRXQRPSIY-UHFFFAOYSA-N
Pubchem ID :45080217

Safety of [ 93366-88-2 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Calculated chemistry of [ 93366-88-2 ] Show Less

Physicochemical Properties

Num. heavy atoms 10
Num. arom. heavy atoms 9
Fraction Csp3 0.0
Num. rotatable bonds 0
Num. H-bond acceptors 2.0
Num. H-bond donors 2.0
Molar Refractivity 38.29
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

67.59 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

0.92
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

0.32
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

0.55
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

-0.43
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

0.89
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

0.45

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-1.54
Solubility 3.88 mg/ml ; 0.0289 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-1.3
Solubility 6.68 mg/ml ; 0.0498 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-2.15
Solubility 0.958 mg/ml ; 0.00714 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

No
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

Yes
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-6.89 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.35

Application In Synthesis [ 93366-88-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 93366-88-2 ]

[ 93366-88-2 ] Synthesis Path-Upstream   1~2

  • 1
  • [ 84955-31-7 ]
  • [ 93366-88-2 ]
YieldReaction ConditionsOperation in experiment
90% With ammonia In methanol; water for 17 h; To a suspension of 2-AMINO-4- CHLORO-7H-PYRROLO [2, 3-d] pyrimidine (1) (1.0 g, 6.0 mmol) in MeOH (50 mL) and aqueous ammonium hydroxide (1 mL) was added 10percent Pd-C (500 mg). The reaction mixture was stirred under atmospheric pressure for 17 h and the catalyst was filtered through A pad of Celite. The filtrate was concentrated and chromatographed with silica gel (CH2CL2 : MEOH = 90: 10) to yield 717 mg of the target compound (90percent). H NMR (DMSO-D6) : 8 11.4 (bs, 1H), 8. 50 (s, 1 H), 7.11 (dd, J= 3. 6,0. 6 HZ, 1H), 6.49 (bs, 2H), 6.32 (dd, J= 3. 6,0. 9 HZ, 1 H).
References: [1] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 18, p. 5261 - 5264.
[2] Patent: WO2004/80466, 2004, A1, . Location in patent: Page/Page column 32.
[3] Liebigs Annalen der Chemie, 1984, # 10, p. 1719 - 1730.
[4] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 1, p. 334 - 337.
  • 2
  • [ 335654-06-3 ]
  • [ 93366-88-2 ]
References: [1] Patent: WO2013/6738, 2013, A1, . Location in patent: Page/Page column 325; 326.
 

Related Products

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 93366-88-2 ]

Amines

Chemical Structure| 1500-85-2

A321813 [1500-85-2]

7H-Pyrrolo[2,3-d]pyrimidin-4-amine

Similarity: 0.77

Chemical Structure| 914349-42-1

A125438 [914349-42-1]

5-(m-Tolyl)pyrimidin-2-amine

Similarity: 0.70

Chemical Structure| 31408-17-0

A415741 [31408-17-0]

5-(p-Tolyl)pyrimidin-2-amine

Similarity: 0.70

Chemical Structure| 39268-71-8

A299723 [39268-71-8]

5-Ethylpyrimidin-2-amine

Similarity: 0.69

Chemical Structure| 514854-12-7

A459331 [514854-12-7]

6-Ethylpyrimidine-2,4-diamine

Similarity: 0.68

Related Parent Nucleus of
[ 93366-88-2 ]

Other Aromatic Heterocycles

Chemical Structure| 271-70-5

A152877 [271-70-5]

7H-Pyrrolo[2,3-d]pyrimidine

Similarity: 0.92

Chemical Structure| 89792-07-4

A136847 [89792-07-4]

2-Methyl-7H-pyrrolo[2,3-d]pyrimidine

Similarity: 0.83

Chemical Structure| 335654-06-3

A134171 [335654-06-3]

2-Chloro-7H-pyrrolo[2,3-d]pyrimidine

Similarity: 0.77

Chemical Structure| 1060815-89-5

A209176 [1060815-89-5]

7H-Pyrrolo[2,3-d]pyrimidine-5-carbaldehyde

Similarity: 0.77

Chemical Structure| 1500-85-2

A321813 [1500-85-2]

7H-Pyrrolo[2,3-d]pyrimidin-4-amine

Similarity: 0.77